Novartis halts malaria drug trial against COVID-19 amid participant shortfall Novartis’ trial began in April and sought to test the drug in 440 hospitalised patients Swiss drugmaker Novartis is halting…
COVID 19 update: FDA revokes emergency use authorization for chloroquine and hydroxychloroquine The FDA determined that chloroquine and hydroxychloroquine are unlikely to be effective in treating COVID-19 for the authorised…
